This Exciting Biotech Stock Could Be Your Next 10-Bagger
The stock performance of 23andMe (NASDAQ: ME) has plunged since it went public last June. But, in this video clip from "The Rank" on Motley Fool Live, recorded on March 28, Fool.com contributors Matt Frankel and Travis Hoium discuss a few of the biotech company's promising business plans that could pay off in a big way over the next few years.
Source Fool.com
